Anika Therapeutics Q4 Swings to Adjusted Loss, Revenue Rises -- Shares Drop After Hours
I'm PortAI, I can summarize articles.
Anika Therapeutics reported a Q4 adjusted loss late Wednesday of $0.03 per share, swinging from adjusted income of $0.07 a year earlier. Two analysts polled by FactSet expected a loss of $0.23. Revenue for the quarter ended Dec. 31 was $30.6 million, up from $30.2 million a year earlier. Two analysts surveyed by FactSet expected $29 million. The company's shares were down 6% in recent after-hours activity.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Trading View The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments